1992
DOI: 10.1001/archopht.1992.01080140089033
|View full text |Cite
|
Sign up to set email alerts
|

Iris Sector Heterochromia as a Marker for Neural Crest Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
4
0

Year Published

2002
2002
2022
2022

Publication Types

Select...
2
2
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 10 publications
0
4
0
Order By: Relevance
“…Histopathologic specimens have shown marked reduction in iris stromal pigmentation and reduced stromal cells in the areas of hypoplasia supporting a hypothesis of a defect in neural crest development. 2 In summary, iris hypoplasia and APSDs are uncommon entities. The distinctive iris appearance in our patients most likely represents extreme iris stromal hypoplasia with apparent absence of the sphincter and dilator muscles.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Histopathologic specimens have shown marked reduction in iris stromal pigmentation and reduced stromal cells in the areas of hypoplasia supporting a hypothesis of a defect in neural crest development. 2 In summary, iris hypoplasia and APSDs are uncommon entities. The distinctive iris appearance in our patients most likely represents extreme iris stromal hypoplasia with apparent absence of the sphincter and dilator muscles.…”
Section: Discussionmentioning
confidence: 99%
“…Hirschsprung disease, Waardenburg syndrome, neuroblastoma, and esophageal motility disorder have all been reported in patients with iris or pupillary defects. [1][2][3]18 In most cases the iris is hypoplastic and presents as stromal thinning and heterochromia. Histopathologic specimens have shown marked reduction in iris stromal pigmentation and reduced stromal cells in the areas of hypoplasia supporting a hypothesis of a defect in neural crest development.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The pattern of malformations and minor anomalies observed in patients with Myhre syndrome including ToF, Hirschsprung disease, schwannoma, nerve sheath tumors, and iris abnormalities suggests that Myhre syndrome may also be viewed as a neurocristopathy (Brazel, 1992; Lewis et al, 2017; Mort et al, 2015; Ritter & Martin, 2019). At least at present, other manifestations of Myhre syndrome, such as short stature and progressive fibrotic changes, might be linked to the specific role of SMAD4 in organization and proliferation of extracellular matrix (Whitaker et al, 2017).…”
Section: Discussionmentioning
confidence: 99%